BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 169 filers reported holding BRIDGEBIO PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.33 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $819,077,805 | +53.3% | 31,060,971 | 0.0% | 28.79% | +74.0% |
Q2 2023 | $534,248,701 | +3.7% | 31,060,971 | 0.0% | 16.54% | +6.7% |
Q1 2023 | $514,990,899 | +117.6% | 31,060,971 | 0.0% | 15.50% | +94.0% |
Q4 2022 | $236,684,599 | -23.3% | 31,060,971 | 0.0% | 7.99% | +28.8% |
Q3 2022 | $308,746,000 | +9.5% | 31,060,971 | 0.0% | 6.20% | +65.4% |
Q2 2022 | $282,034,000 | -10.5% | 31,060,971 | 0.0% | 3.75% | +31.2% |
Q1 2022 | $315,269,000 | -39.1% | 31,060,971 | 0.0% | 2.86% | +0.6% |
Q4 2021 | $518,097,000 | -64.4% | 31,060,971 | 0.0% | 2.84% | -60.9% |
Q3 2021 | $1,455,828,000 | -23.1% | 31,060,971 | 0.0% | 7.26% | -5.4% |
Q2 2021 | $1,893,477,000 | -1.0% | 31,060,971 | 0.0% | 7.68% | -20.3% |
Q1 2021 | $1,913,356,000 | -22.0% | 31,060,971 | -10.0% | 9.64% | -22.6% |
Q4 2020 | $2,454,075,000 | +89.5% | 34,510,971 | 0.0% | 12.45% | +68.4% |
Q3 2020 | $1,294,852,000 | +15.1% | 34,510,971 | 0.0% | 7.40% | +7.7% |
Q2 2020 | $1,125,403,000 | +5.2% | 34,510,971 | -6.5% | 6.87% | +0.6% |
Q1 2020 | $1,070,119,000 | -17.3% | 36,900,661 | 0.0% | 6.83% | +8.0% |
Q4 2019 | $1,293,368,000 | +63.3% | 36,900,661 | 0.0% | 6.32% | +41.9% |
Q3 2019 | $792,257,000 | -20.4% | 36,900,661 | 0.0% | 4.46% | -63.7% |
Q2 2019 | $995,211,000 | – | 36,900,661 | – | 12.26% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 6,068,125 | $55,099,000 | 39.31% |
M28 Capital Management LP | 466,200 | $4,233,000 | 4.74% |
Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $282,034,000 | 3.75% |
Octagon Capital Advisors LP | 933,743 | $8,478,000 | 2.26% |
VIKING GLOBAL INVESTORS LP | 26,620,991 | $241,719,000 | 1.11% |
HHLR ADVISORS, LTD. | 5,362,014 | $48,687,000 | 1.04% |
Cormorant Asset Management, LP | 1,469,179 | $13,340,000 | 1.01% |
Knott David M Jr | 213,206 | $1,936,000 | 0.81% |
Fernwood Investment Management, LLC | 183,900 | $1,670,000 | 0.72% |
HighVista Strategies LLC | 105,942 | $962,000 | 0.58% |